Urgent.News

What's breaking now, across thousands of outlets.

More in Health & Medicine

Daewoong Pharma Takes P-CAB Drug Fexuclue Into Indonesia

Daewoong Pharmaceutical has launched its homegrown gastroesophageal reflux disease (GERD) treatment Fexuclue in Indonesia, opening another front in the company’s push to expand its gastrointestinal…

  • Daewoong Pharma launches GERD drug Fexuclue in Indonesia.
  • Fexuclue receives Indonesian approval for erosive GERD treatment.
  • Company targets Indonesia's growing gastrointestinal drug market.

More from Wednesday 23 September →